Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Anxiety Disorders Among Recovered Patients With Substance Dependence

A Follow-up Study

Shams Eldin, Ahmed F., MSc; Raslan, Mostafa R., MD; Madbouly, Nagwan M., MD; Enaba, Dalia A., MD

Addictive Disorders & Their Treatment: June 2019 - Volume 18 - Issue 2 - p 81–88
doi: 10.1097/ADT.0000000000000153
Original Articles

Objectives: The combination of substance dependence and anxiety disorders is recognized to be increasingly common. The aim of this study was to assess the presence of anxiety disorders in recovered patients with substance dependence and to determine the prevailing types of anxiety disorders among these patients.

Materials and Methods: Subjects diagnosed with substance dependence were recruited from the outpatient clinic of the Psychiatry and Addiction Prevention Hospital in Kasr Al Ainy. Patients were diagnosed by the Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I) for Anxiety Disorders and Substance Dependence Disorders. Urine screening test was performed for all participants. Baseline assessment was carried out after 1 month of quitting the substance intake; thereafter, the same assessment was repeated after 6 months.

Results: There was a high prevalence (94%) of anxiety disorders in recovered patients with ≥6 months abstinence from substance dependence. Specific phobic disorder was the most prevalent type in recovered patients (20%), followed by social anxiety disorder (18%). There was a statistically significant relation between the main type of substance used and generalized anxiety disorder.

Conclusions: Anxiety disorders are common in recovered patients with substance dependence. Specific phobic disorder was the most commonly diagnosed anxiety disorder in these patients.

Psychiatry Department, Cairo University, Cairo, Egypt

The authors declare no conflict of interest.

Reprints: Nagwan M. Madbouly, MD, Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo 11569, Egypt (e-mail:

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved